Source link : https://newshealth.biz/health-news/heres-the-data-supporting-pegcetacoplans-approval-in-two-rare-kidney-diseases/
(MedPage Today) — Pegcetacoplan (Empaveli) reduced proteinuria and helped stabilize kidney function in patients with C3 glomerulopathy or primary immune-complex membranoproliferative glomerulonephritis (MPGN), the phase III VALIANT trial found… Source link : https://www.medpagetoday.com/nephrology/generalnephrology/118824 Author : Publish date : 2025-12-03 23:16:00 Copyright for syndicated content belongs to the linked Source.
The post Here’s the Data Supporting Pegcetacoplan’s Approval in Two Rare Kidney Diseases first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-03 23:16:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8